Lupin Launches Darunavir Tablets in the United States

Market news

Lupin Launches Darunavir Tablets in the US.

Major  Pharma Player Lupin Limited (Lupin) today announced the launch of Darunavir Tablets, 600 mg and 800 mg, to market a generic equivalent of Prezista® Tablets of Janssen Products, LP.

Darunavir Tablets, 600 mg and 800 mg (RLD Prezista®) had estimate Annual sales of USD 308 million in the U.S. (IQVIA MAT March 2023).

Leave a comment